Revvity (RVTY) Financials: Revenue & Earnings
RVTY$165.94+0.60 +0.37%
$18.52B
Market Cap
78.73
P/E
30.98
Forward P/E
37
Score
Revvity (RVTY) Financials: Revenue & Earnings
RVTY price $165.94 +0.60 +0.37%
- Ticker
- RVTY
- Price
- $165.94
- Change
- +0.60 +0.37%
- Market cap ?
- $18.52B
- P/E ?
- 78.73
- Forward P/E ?
- 30.98
- Dividend yield ?
- 0.17%
- Beta ?
- 1.06
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Stocklytics score
- 37
- Value
- 28
- Quality
- 45
- Growth
- 38
Stocklytics score rationale: value 28, quality 45, growth 38.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 2115516999 | 2256982000 | 2777996000 | 2883673000 | 3782745000 | 3827808000 | 3311822000 | 2750571000 | 2755026000 | 2856051000 |
Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced instrumentation, reagents…
Earnings and financials
Revvity, Inc. (RVTY) trades at $165.94, with a market cap of $18.52B and a trailing P/E of 78.73. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 2115516999 | 2256982000 | 2777996000 | 2883673000 | 3782745000 | 3827808000 | 3311822000 | 2750571000 | 2755026000 | 2856051000 |
Insights · Dividends · Forecast · Financials · Learn